$3.36
-0.0111-0.33%
Last update: Oct 22, 7:07 AM
Passage Bio Inc
PASGNASDAQ
Passage Bio (PASG) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-2.71 | $-2.87 | $-2.55 | $-2.84 |
| Actual | $-2.44 | $-2.36 | $-4.09 | $-2.44 |
| Surprise | +9.96% | +17.8% | -60.4% | +14.1% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | — |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-3.49 | $-3.76 |
| Revenue | ||
| Consensus | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $-2.44 | $-2.71 | 9.96 % |
| Q1 | May 12, 2026 | $-2.36 | $-2.87 | 17.8 % |
| Q4 | Mar 3, 2026 | $-4.09 | $-2.55 | -60.4 % |
| Q3 | Nov 10, 2025 | $-2.44 | $-2.84 | 14.1 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 13, 2024 | $0 | $3.33M | -100.0 % |
